Genetics
Home › Medical research › Spinal cord injury (spasticity)
Insufficient evidence

Spinal cord injury (spasticity) & cannabis

The 2017 National Academies review found insufficient evidence for cannabinoids as a treatment for spasticity caused by spinal cord injury. Findings from multiple sclerosis do not establish benefit for this condition.

Sources: NASEM 2017

Most-studied cannabinoids

THCCBD

Safety & cautions

Uncertain benefit; central-nervous-system side effects can occur.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.